In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. The enthusiasm for digital approaches involving sensors, apps, and wearables that could transmit information across systems, commonly grouped under the term Internet of Things, also spread. Yet, despite the landmark FDA approval, digital pills have not exploded in pharma. Privacy and logistical concerns, especially while studying such applications for vulnerable populations, have lingered.
Regenerative medicine, in conjunction with personalized medicine, is responsible for the next major paradigm shift in modern medicine. However, neither regenerative nor personalized precision medicine are subjects traditionally found in the curriculum of U.S. medical schools. As such, this emergence has been met with skepticism, doubt and confusion.
EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced the appointment of Karen Zaderej to its Board of Directors. Ms. Zaderej is currently the President, Chief Executive Officer and Chair of the Board at UF Startup and Accelerate graduate AxoGen, Inc., and brings more than 35 years of biopharmaceutical and medical device experience to the role.
The U.S. Department of Homeland Security (DHS) announced that UF startup and Accelerate resident Micro Nano Technologies, as one of their winners in the Cooling Solutions Challenge prize competition. The winners were each awarded funding, which totaled $195,000, for their innovative and creative ideas that sought climate-friendly cooling solutions to protect people in extreme heat conditions.
Canaery, the neurotech startup digitizing the sense of smell to enhance the way we perceive and monitor the world around us, announced today it has closed more than $4 million in seed funding to accelerate the development of its scent-sensing platform.
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a biotech company dedicated to fighting infectious diseases including coronaviruses, announces the appointment of Ms. Kimberly M. Murphy, member of the Board of Directors, as President and Chief Executive Officer effective June 23, 2022. Ms. Murphy brings more than 25 years of vaccine industry experience at leading pharmaceutical companies including serving as a key leader in the successful US and Global launch of Merck’s HPV/Gardasil Franchise. Ms. Murphy joined Oragenics’ Board of Directors in 2020.
Context Labs, an enterprise data fabric climate technology company, announced a platform partnership with Encino Environmental Services, LLC and Satlantis, LLC, further building a technology ecosystem to measure emissions with high precision, bringing greater urgency and rigor to combatting climate change.
UF Innovate | Sid Martin Biotech alum Amend Surgical, Inc., an Alachua-based medical device company, announced that it has finalized a funding agreement with the Institute for Commercialization of Florida Technology (the Florida Institute) along with being awarded a substantial product development funding from The Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center.
UF startup Micro Nano Technologies, announced as finalists in the Cooling Solutions Challenge prize competition. Launched in September 2021, by DHS Science and Technology Directorate (S&T) and the Federal Emergency Management Agency (FEMA), this $195,000 prize competition marks the first in a series focusing on national climate resilience.
Entrinsic Bioscience and its licensee Nuvara Therapeutics announce they are one step closer to using RxAA formulations as a therapy for patients with Cystic Fibrosis Class I mutations